Roche Diabetes Testing Innovations Highlighted at 18th Annual Congress of The Lebanese Society of Endocrinology, Diabetes & Lipids
DUBAI, UAE, 6 July 2014: Dr. Andreas Reichel, Medical Director, University Hospital Carl-Gustav-Carus at the Technical University Dresden, spoke at the 18th Annual Congress of The Lebanese Society of Endocrinology, Diabetes & Lipids in Beirut last month, highlighting the benefits of modern insulin pump therapy, as part of a symposium granted by Roche Diabetes Care. The three-day event is an annual international platform that aims to update the medical community on topics that are of interest and common use to endocrinology and diabetes professionals.
Speaking after his symposium, Dr. Reichel said: “Modern insulin pump therapy has numerous benefits- chief of these is its ability to eliminate individual insulin injections, particularly at night, when the patient is more exposed to nighttime dips in blood sugar levels. Insulin pumps like Roche’s Accu-Chek® Combo help to better manage the amount of insulin a patient requires while (s)he is in sleep state.”
According to the International Diabetes Federation, 387 million people globally have diabetes- and more than 37 million people of these currently reside in the MENA Region. By 2035 this figure is expected to rise to 68 million. In Lebanon, which is one of the IDF’s member countries, 494,300 cases of diabetes were registered in 2014.
“The region faces challenges when it comes to diabetes management, but if this congress is any indication, people here are very receptive to modern treatment methods, and steps are being taken to combat rising diabetes figures,” said Dr. Reichel.